Annual EBITDA
-$17.03 M
+$43.82 M+72.01%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual earnings before interest, taxes, depreciation & amortization is currently -$17.03 million, with the most recent change of +$43.82 million (+72.01%) on 31 December 2023. ZBIO annual EBITDA is now at all-time high.ZBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$40.95 M
-$1.28 M-3.23%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly earnings before interest, taxes, depreciation & amortization is currently -$40.95 million, with the most recent change of -$1.28 million (-3.23%) on 30 September 2024. Over the past year, it has dropped by -$76.60 million (-214.86%). ZBIO quarterly EBITDA is now -214.86% below its all-time high of $35.65 million, reached on 30 September 2023.ZBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$132.91 M
-$76.60 M-136.03%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM earnings before interest, taxes, depreciation & amortization is currently -$132.91 million, with the most recent change of -$76.60 million (-136.03%) on 30 September 2024. Over the past year, it has dropped by -$168.56 million (-472.82%). ZBIO TTM EBITDA is now -472.82% below its all-time high of $35.65 million, reached on 30 September 2023.ZBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +72.0% | -214.9% | -472.8% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZBIO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +72.0% | -214.9% | at low | -472.8% | at low |
| 5 y | 5 years | at high | +72.0% | -214.9% | at low | -472.8% | at low |
| alltime | all time | at high | +72.0% | -214.9% | at low | -472.8% | at low |
ProShares UltraPro Short Nasdaq Biotechnology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$40.95 M(+3.2%) | -$132.91 M(+136.0%) |
| June 2024 | - | -$39.67 M(+44.0%) | -$56.31 M(+238.3%) |
| Mar 2024 | - | -$27.55 M(+11.3%) | -$16.64 M(-252.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$17.03 M(-72.0%) | -$24.75 M(-169.4%) | $10.90 M(-69.4%) |
| Sept 2023 | - | $35.65 M | $35.65 M |
| Dec 2022 | -$60.85 M | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual EBITDA year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly EBITDA year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM EBITDA year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ZBIO is -$17.03 M
What is the all time high annual EBITDA for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual earnings before interest, taxes, depreciation & amortization is -$17.03 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual EBITDA year-on-year change?
Over the past year, ZBIO annual earnings before interest, taxes, depreciation & amortization has changed by +$43.82 M (+72.01%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ZBIO is -$40.95 M
What is the all time high quarterly EBITDA for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly earnings before interest, taxes, depreciation & amortization is $35.65 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly EBITDA year-on-year change?
Over the past year, ZBIO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$76.60 M (-214.86%)
What is ProShares UltraPro Short Nasdaq Biotechnology TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ZBIO is -$132.91 M
What is the all time high TTM EBITDA for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM earnings before interest, taxes, depreciation & amortization is $35.65 M
What is ProShares UltraPro Short Nasdaq Biotechnology TTM EBITDA year-on-year change?
Over the past year, ZBIO TTM earnings before interest, taxes, depreciation & amortization has changed by -$168.56 M (-472.82%)